Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:43 PM
Ignite Modification Date:
2025-12-24 @ 11:43 PM
NCT ID:
NCT03607851
Eligibility Criteria:
Inclusion Criteria:
* Adults aged 18-85 years old
* Patients diagnosed with focal epilepsy
* Patients subjected to the addition of lacosamide to treat focal onset seizures according to physician's judgement
* Subjects provided informed consent
Exclusion Criteria:
* Subjects who changed other antiepileptic drugs at the beginning of lacosamide treatment
* Subjects with unstable physical, mental or other disease condition that can impede with accurate evaluation or treatment
* Subjects with terminal illness or general medical condition that can impede with the participation of the clinical trial
* Subjects who do not agree with prior consent
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
85 Years
Study:
NCT03607851
Study Brief:
Protocol Section:
NCT03607851